Panagora Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Buy |
72,059
+21,605
| +43% | +$82.7K | ﹤0.01% | 959 |
|
|
2025
Q1 | $290K | Sell |
50,454
-125,554
| -71% | -$722K | ﹤0.01% | 943 |
|
|
2024
Q4 | $878K | Buy |
176,008
+39,658
| +29% | +$198K | ﹤0.01% | 688 |
|
|
2024
Q3 | $735K | Buy |
136,350
+76,052
| +126% | +$410K | ﹤0.01% | 813 |
|
|
2024
Q2 | $200K | Buy |
+60,298
| New | +$200K | ﹤0.01% | 1138 |
|
|
2021
Q3 | – | Sell |
-460
| Closed | -$5K | – | 1719 |
|
|
2021
Q2 | $5K | Sell |
460
-103
| -18% | -$1.12K | ﹤0.01% | 2475 |
|
|
2021
Q1 | $7K | Hold |
563
| – | – | ﹤0.01% | 2492 |
|
|
2020
Q4 | $4K | Buy |
+563
| New | +$4K | ﹤0.01% | 2507 |
|
|
2020
Q2 | – | Sell |
-39,632
| Closed | -$98K | – | 2557 |
|
|
2020
Q1 | $98K | Buy |
39,632
+20,184
| +104% | +$49.9K | ﹤0.01% | 1702 |
|
|
2019
Q4 | $113K | Buy |
+19,448
| New | +$113K | ﹤0.01% | 1769 |
|